Trials / Completed
CompletedNCT01324336
Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Children's Mercy Hospital Kansas City · Academic / Other
- Sex
- All
- Age
- 4 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the pharmacokinetics of a routinely used compounded liquid formulation of 6-mercaptopurine (6-MP) with commercially available tablets in patients who are receiving treatment with 6-MP as part of their clinical treatment for acute lymphoblastic leukemia (ALL).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6-Mercaptopurine | 75 mg/m2/dose/day |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2011-03-29
- Last updated
- 2021-01-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01324336. Inclusion in this directory is not an endorsement.